Literature DB >> 11016462

Radical surgery for gallbladder cancer: current options.

A Muratore1, R Polastri, L Capussotti.   

Abstract

Gallbladder carcinoma is the most common malignancy of the biliary tract. There are still many controversies regarding the type of curative surgical treatment for each stage of the disease. The staging system used is the TNM classification of the International Union Against Cancer. Different patterns of spread characterize gallbladder cancer but the two main types are direct invasion and lymph node metastases; since only the depth of invasion can be easily recognized by imaging techniques, it becomes the main variable in choosing the appropriate surgical treatment. Most Tis and T1 tumours are incidentally discovered after cholecystectomy for cholelithiasis and no further therapy is requested; for pT1b tumours, relaparotomy with hepatic resection and N1 dissection is associated with a better survival. For T2 tumours, cholecystectomy with hepatic resection and dissection of N1-2 lymph nodes is the standard treatment, with a 5-year survival of 60-80%. The only chance of long-term survival for patients with a T3-T4 tumour is an extended operation combining an hepatic resection with an N1-2 dissection with or without excision of the common bile duct. A subset of patients with peripancreatic positive nodes or invasion of adjacent organs seems to benefit from a synchronous pancreaticoduodenectomy.

Entities:  

Mesh:

Year:  2000        PMID: 11016462     DOI: 10.1053/ejso.1999.0918

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  24 in total

1.  Comparative analysis between clinical outcomes of primary radical resection and second completion radical resection for T2 gallbladder cancer: single-center experience.

Authors:  Seong Yeon Cho; Sang-Jae Park; Seong Hoon Kim; Sung-Sik Han; Young-Kyu Kim; Kwang-Woong Lee
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

2.  Simultaneous detection of synchronous colonic and biliary carcinoma by abdominal ultrasonography in two patients with ulcerative colitis.

Authors:  R D Klingenberg-Noftz; N Homann; I Bos; H P Bruch; D Ludwig
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

3.  Gallbladder carcinoma with ultrasonographically intact outer hyperechoic layer: A sign of a favorable outcome.

Authors:  Masanobu Iri; Yasuaki Takehara; Kazuhiko Matsuzawa; Hideaki Yasui; Teruaki Oka
Journal:  J Med Ultrason (2001)       Date:  2002-09       Impact factor: 1.314

Review 4.  Gallbladder carcinoma incidentally encountered during laparoscopic cholecystectomy: how to deal with it.

Authors:  Ketao Jin; Huanrong Lan; Tieming Zhu; Kuifeng He; Lisong Teng
Journal:  Clin Transl Oncol       Date:  2011-01       Impact factor: 3.405

5.  Effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells.

Authors:  Yue-Zu Fan; Jin-Ye Fu; Ze-Ming Zhao; Cun-Qiu Chen
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

6.  Analysis of gallbladder polypoid lesion size as an indication of the risk of gallbladder cancer.

Authors:  Ji Eun Sung; Chang Woo Nam; Yang Won Nah; Byung Sung Kim
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2014-02-24

7.  Gallbladder cancer.

Authors:  Sanjeev Misra; Arun Chaturvedi; N C Misra
Journal:  Curr Treat Options Gastroenterol       Date:  2006-04

8.  Revision surgery for incidental gallbladder cancer: factors influencing operability and further evidence for T1b tumours.

Authors:  P J Shukla; G Barreto; A Kakade; S V Shrikhande
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

9.  Incidental gallbladder carcinoma diagnosed during or after laparoscopic cholecystectomy.

Authors:  Wei-Jie Zhang; Gui-Fang Xu; Xiao-Ping Zou; Wei-Bing Wang; Jun-Chi Yu; Guo-Zhong Wu; Chun-Lei Lu
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

10.  A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate?

Authors:  Danielle M Hari; J Harrison Howard; Anna M Leung; Connie G Chui; Myung-Shin Sim; Anton J Bilchik
Journal:  HPB (Oxford)       Date:  2012-09-26       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.